The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data
Abstract
Background: In an earlier publication, our evaluation of data from breast cancer screening programs in seven Swedish counties suggested a 40% reduction in incidence-based breast cancer mortality among women actually screened. In the current study, we expand the previous analysis from seven counties to 13 large areas within nine counties, including six of the original counties and seven additional areas, examine a longer period of follow-up (20-44 years), apply new analytic methods for the evaluation of incidence-based breast cancer mortality, and estimate the number needed to screen to save one life. Methods: Data from six of the original counties (one being excluded as it does not yet have 10 years of follow-up after the initiation of screening), with increased follow-up, and seven additional large areas, within three counties, representing ∼45% of Swedish women, provide information about age at diagnosis, age at death, and screening history for 542,187 women in the prescreening and 566,423 women in the screening epochs. Regardless of year of diagnosis, there were a total of 6,231 deaths due to breast cancer in the period of study as a whole. Of these, 4,778 were incidence-based deaths in the two epochs, i.e., death among cases diagnosed within either the prescreening or screening period. Data were analyzed using Poisson regression and adjusted, when necessary, for self-selection bias, contemporaneous changes in incidence, and changes in mortality independent of screening. Results: Attendance was uniformly high, averaging 75% in the screening epochs. Recall rates for assessment varied from 4% to 5% at the first round of screening and ∼3% at later rounds. Detection rates averaged five breast cancers per 1,000 women screened in the first round, and four breast cancers per 1,000 women screened in subsequent rounds. There was a significant 45% reduction in incidence-based breast cancer mortality among screened women in the screening epoch relative to incidence-based breast cancer mortality in the prescreening epoch (relative risk, 0.55; 95% confidence intervals, 0.51-0.59). After adjusting for self-selection bias, there still was a significant 43% reduction in incidence-based breast cancer mortality associated with screening (relative risk, 0.57; 95% confidence intervals, 0.53-0.62). Conclusions: These results indicate a reduction in breast cancer mortality of between 40% and 45% in association with screening, after adjustment for self-selection bias. These results were obtained with modest human costs: the number needed to screen to save one life was estimated as 472. (Cancer Epidemiol Biomarkers Prev 2006;15(1):45–51)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Breast cancer screening with mammography: overview of Swedish randomised trials
Nyström, L., Wall, S., Rutqvist, L. E., Lindgren, A., Lindqvist, M., Rydén, S., Andersson, J., Bjurstam, N., Fagerberg, G., Frisell, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91067-v · Cited by 968
Tabar, L., Yen, M.-F., Vitak, B., Chen, H.-H. T., Smith, R. A., & Duffy, S. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13143-1 · Cited by 742
THE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER
Tabár, L., Vitak, B., Chen, H.-H., Duffy, S. W., Yen, M.-F., Chiang, C.-F., Krusemo, U. B., Tot, T., & Smith, R. A. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70191-3 · Cited by 460
Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986
Miller, A. B., Shapiro, S., Venet, W., Strax, P., & Venet, L. (1989) · Journal of Public Health Policy · doi:10.2307/3342801 · Cited by 438
Duffy, S. W., Tabár, L., Chen, H., Holmqvist, M., Yen, M., Abdsalah, S., Epstein, B., Frodis, E., Ljungberg, E., Hedborg‐Melander, C., et al. (2002) · Cancer · doi:10.1002/cncr.10765 · Cited by 429
Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of Age
Black, W. C., Nease, R. F., & Tosteson, A. N. A. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.720 · Cited by 406
Cited by
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0969 · Cited by 611
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Metadata
- Authors
- The Swedish Organised Service Screening Evaluation Group
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2006-01-01
- Volume
- 15
- Issue
- 1
- Pages
- 45-51
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W1558381762
- Cited by
- 258
- References
- 19
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. https://app.cochat.ai/papers/10.1158/1055-9965.epi-05-0349
- The paper
- The Swedish Organised Service Screening Evaluation Group. (2006). Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-05-0349
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.